Compare Chemfab Alka. with Similar Stocks
Dashboard
Poor long term growth as Operating profit has grown by an annual rate -201.97% of over the last 5 years
Flat results in Jun 26
Risky - Negative Operating Profits
Despite the size of the company, domestic mutual funds hold only 0.25% of the company
Below par performance in long term as well as near term
Stock DNA
Commodity Chemicals
INR 549 Cr (Micro Cap)
NA (Loss Making)
44
0.32%
0.30
-0.91%
1.45
Total Returns (Price + Dividend) 
Latest dividend: 1.2 per share ex-dividend date: Sep-04-2025
Risk Adjusted Returns v/s 
Returns Beta
News

Chemfab Alkalis Ltd is Rated Sell
Chemfab Alkalis Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 10 August 2026. While the rating was revised on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 15 August 2026.
Read full news article
Chemfab Alkalis Ltd Sees Mixed Technical Signals Amid Mild Momentum Shift
Chemfab Alkalis Ltd has exhibited a notable shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, reflecting a complex interplay of technical indicators. Despite a 3.18% gain on 14 Aug 2026, the micro-cap commodity chemicals firm remains under pressure with a MarketsMOJO Mojo Score of 31.0 and a Sell grade, albeit improved from a Strong Sell rating just days earlier.
Read full news article
Chemfab Alkalis Ltd Technical Momentum Shifts Amid Bearish Sentiment
Chemfab Alkalis Ltd, a micro-cap player in the commodity chemicals sector, has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Strong Sell to a Sell rating reflects deteriorating market sentiment, compounded by a 2.9% decline in its share price to ₹368.00 on 13 Aug 2026. This article analyses the technical parameters shaping the stock’s outlook and contextualises its performance against broader market benchmarks.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
05-Aug-2026 | Source : BSESubmission of copy of newspaper publication wrt. SEBI circular dated 30th Jan 2026 on special window for transfer and dematerialisation of physical securities.
Announcement under Regulation 30 (LODR)-Newspaper Publication
31-Jul-2026 | Source : BSESubmission of Newspaper Clippings of Un-Audited Financial Results for the quarter ended 30th June 2026 approved vide board meeting held on 29th July 2026.
Investor Presentation For Quarter Ended 30Th June 2026
30-Jul-2026 | Source : BSESubmission of Investor Presentation for the quarter ended 30th June 2026
Corporate Actions 
No Upcoming Board Meetings
Chemfab Alkalis Ltd has declared 12% dividend, ex-date: 04 Sep 25
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 2 Schemes (0.07%)
Held by 2 FIIs (0.04%)
Dr Rao Holdings Pte Ltd (47.04%)
V. M. Srinivasan (1.8%)
21.7%
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
QoQ Growth in quarter ended Jun 2026 is -2.17% vs 9.74% in Mar 2026
QoQ Growth in quarter ended Jun 2026 is 1,093.75% vs 110.79% in Mar 2026
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 6.10% vs -0.14% in Sep 2024
Growth in half year ended Sep 2025 is 50.00% vs -97.39% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'25
YoY Growth in nine months ended Dec 2025 is -2.40% vs -1.20% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -274.55% vs -89.29% in Dec 2024
Annual Results Snapshot (Consolidated) - Mar'26
YoY Growth in year ended Mar 2026 is -6.98% vs 2.16% in Mar 2025
YoY Growth in year ended Mar 2026 is 50.58% vs -126.37% in Mar 2025






